Form D · Biotechnology

Portal Biotechnologies, Inc.

Arlington, MA · CIK 0002049466

Offering snapshot reported May 29, 2026 · SEC filing

Reported sold
$11.7M
Offering amount: $11.9M
Investors reported
43
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Dec 11, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.85M$11.7MDec 26, 2024: $11,694,998.00Dec 26, 2024May 29, 2026: $11,694,998.00May 29, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Minimum accepted$7,500 → $9,999

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 29, 2026Amendment$11,694,998$0vs Dec 26, 202443SEC filing
May 29, 2026Initial$8,999,999No comparison12SEC filing
Dec 26, 2024Initial$11,694,998No comparison43SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-533355

Source: Form D, filed May 29, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alec Barlcay Director, Executive
Armon Sharei Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
27 Brunswick Rd.
Arlington, MA, 02476